← FDA Drug Approvals (Drugs@FDA)

METHOCARBAMOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2017-07-31

Drug application

FDA Application #

ANDA207522

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHOCARBAMOL

Generic name

METHOCARBAMOL

Active ingredients

METHOCARBAMOL

Dosage form

SOLUTION

Route

IM-IV

Marketing status

Prescription

Sponsor

SOMERSET THERAPS LLC

Manufacturer

Somerset Therapeutics, LLC

First approval

2017-07-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown